Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04086719 · ClinicalTrials.gov registry record · Phase 1
An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT04086719 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 16 participants.
The verdict
NCT04086719, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Study of what the body does to drug BMS-986165 when it is taken together with pyrimethamine
Interventions
- DRUG Pyrimethamine
- DRUG BMS-986165
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-09-12 |
| Est. Completion | 2019-10-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04086719
The ClinicalTrials.gov registry entry for NCT04086719 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pyrimethamine is the first listed.
NCT04086719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04086719 about?
NCT04086719 is a clinical study titled "An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.". Study of what the body does to drug BMS-986165 when it is taken together with pyrimethamine
What is the current status of trial NCT04086719?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2019-09-12. Estimated completion is 2019-10-29.
What interventions are being tested in trial NCT04086719?
The interventions under investigation include: Pyrimethamine (DRUG), BMS-986165 (DRUG).
Who is sponsoring clinical trial NCT04086719?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.